# A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

> **NCT02873598** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 14 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** FOLFIRINOX or gemcitabine/abraxane
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT02873598
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-17
- **Primary completion:** 2019-06-07
- **Final completion:** 2022-11-28
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873598, "A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02873598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*